AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bioscience company retains McDermott Will & Emery.

Women's Health Weekly

| September 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 SEP 2 - (NewsRx.com & NewsRx.net) -- PURE Bioscience (OTCBB:PURE) announced that it has retained the law firm of McDermott Will & Emery to fortify the intellectual property protection of its silver dihydrogen citrate technology.

Firm Partner Cathryn Campbell, PhD, will focus on PURE's silver dihydrogen citrate pharmaceutical Patent Portfolio. Campbell serves as cochair of the firm's Life Sciences Group and is also head of the firm's San Diego Intellectual Property and Life Sciences IP practices.

Campbell, who has been practicing in the areas of biotechnology intellectual property more than 23 years, concentrates her practice on biotechnology patent law and has extensive experience in developing patent portfolio strategies, negotiating and drafting license agreements and preparing patentability, validity, infringement and freedom to operate opinions. She represents biotechnology and pharmaceutical companies, as well as numerous non-profit universities and institutions.

Campbell has been recognized by California Lawyer as one of the state's top patent lawyers.

McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1000 lawyers, McDermott Will & Emery has offices in Boston, Brussels, Chicago, Dusseldorf, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Rome, San Diego, Silicon Valley and Washington, D.C.

The firm's Intellectual Property (IP) Department includes more than 160 lawyers and patent agents working in all of its offices throughout the world. McDermott Will & Emery is renowned for its IP trial and appellate experience, and it is ranked as one of the strongest IP litigation firms for both plaintiffs and defendants.

PURE Bioscience's antimicrobial technologies lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. This new molecule, silver dihydrogen citrate (SDC), is an electrolytically generated ...

Related articles from newspapers, magazines, journals, and more
PURE Bioscience Strengthens Intellectual Property Protection by Retaining...
Press release article from: Business Wire August 3, 2004 700+ words
...Portfolio PURE Bioscience (OTCBB...fortify the intellectual property protection...biotechnology intellectual property more than...firm's Intellectual Property (IP) Department...defendants. PURE Bioscience's antimicrobial...
PURE Bioscience Granted US Patent on 14 New Ionic Silver/Organic Acid Complexes.
Press release article from: Business Wire August 29, 2007 700+ words
...SDC SAN DIEGO -- PURE Bioscience (OTCBB:PURE...President and CEO of PURE Bioscience, stated, "In...significantly expands our intellectual property portfolio. The...owned subsidiary of PURE Bioscience, and Michael L...
BoonMarket.com Announces Coverage of PURE Bioscience.
Press release article from: M2 Presswire August 30, 2007 700+ words
...Organic Acid Complexes PURE Bioscience today announced...President and CEO of PURE Bioscience, stated, "In...significantly expands our intellectual property portfolio. The...About PURE Bioscience PURE Bioscience...
Penny Stock Message Boards - Todays Hot List PURE Bioscience, American Commerce...
Press release article from: M2 Presswire August 29, 2007 700+ words
...watch today include PURE Bioscience (OTCBB:PURE...OTCBB: UGTH). PURE Bioscience (OTCBB:PURE...President and CEO of PURE Bioscience, stated, "In...significantly expands our intellectual property portfolio. The...
PURE Bioscience Files Additional U.S. Patent on Silver Dihydrogen Citrate...
Press release article from: Business Wire June 7, 2004 700+ words
...Krall, President and CEO of PURE Bioscience, stated, "We are pleased...protect our Axenohl related intellectual property." PURE has already obtained...a wholly owned subsidiary of PURE Bioscience. PURE Bioscience's new molecule...
PURE Bioscience Files Patent for Additional Silver Dihydrogen Citrate...
Press release article from: Business Wire September 1, 2004 700+ words
...Traditional Compounds PURE Bioscience (OTCBB:PURE) today...published by the World Intellectual Property Organization (www.wipo...healthcare products. About PURE Bioscience PURE Bioscience (PURE) develops and...
PURE Bioscience Signs Contract to Sell Water Treatment Division by the End of...
Press release article from: Business Wire May 20, 2005 700+ words
SAN DIEGO -- PURE Bioscience (OTCBB:PURE...President and CEO of PURE Bioscience, stated, "Following...regulatory and intellectual property work for development...label brands. About PURE Bioscience PURE Bioscience...
PURE Bioscience Issues Cease and Desist Letter and Rebuts Fictitious Claims By...
Press release article from: Business Wire October 28, 2005 700+ words
SAN DIEGO -- PURE Bioscience (OTCBB:PURE...statements regarding PURE Bioscience. PURE Bioscience...General Counsel for PURE Bioscience. PURE is represented...our company, our intellectual property and our shareholders...
For more facts and information, see all results

Source: HighBeam Research, Bioscience company retains McDermott Will & Emery.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA